<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="gs.css">
    <title>govt scheme</title>
</head>
<body>
    <div>
        <div class="ok">
            <a>Govt Launched Schemes</a>
        </div>
    <h1 id="h">Janani Shishu Suraksha Karyakram</h1>
    <p class="gh">Janani Shishu Suraksha Karyakram (JSSK) (under which free drugs, free diagnostics, free blood and diet, free transport from home to institution, between facilities in case of a referral and drop back home is provided)
        Mobile Medical Units (MMUs) & Telemedicine are also being implemented with NHM support to improve healthcare access particularly in rural areas.
        Under the Atmanirbharta initiative of the Government, Department of Pharmaceuticals launched the PLI scheme for pharmaceuticals in 2021.
        With an objective to enhance India’s manufacturing capabilities and contributing to product diversification towards high value goods in the pharmaceutical sector, 3 different categories of products are being supported under the scheme, viz,
        •	Category 1: Biopharmaceuticals; Complex generic drugs; Patented drugs or drugs nearing patent expiry; Cell based or gene therapy drugs; Orphan drugs; Special emptQQy capsules, Complex excipients,
        •	Category 2: Bulk drugs (except those 41 eligible products notified under “PLI Scheme for Bulk drugs) and
        •	Category 3: Drugs not covered under Category 1 and Category 2 such as Repurposed drugs; Auto immune drugs, anti-cancer drugs, anti-diabetic drugs, anti-infective drugs, cardiovascular drugs, psychotropic drugs and anti-retroviral drugs, including In vitro diagnostic devices (applicable to 5 applicants out of 55 applicants)
        Pradhan Mantri Janaushadhi Pariyojna (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India in November, 2008. Under the scheme dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices.
        </p><br><br><br><br><br>

<h1 id="h">Pradhan Mantri Janaushadhi Pariyojna </h1>
<p class="c2">Pradhan Mantri Janaushadhi Pariyojna (PMBJP) was launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India in November, 2008. Under the scheme dedicated outlets known as Janaushadhi Kendras are opened to provide generic medicines at affordable prices.
    •	The Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) has been notified to boost domestic manufacturing of bulk drugs and reduce import dependence.
    •	Under the scheme, financial incentives will be provided on incremental sales of 41 products given in the guidelines. The incentives will be provided for a period of 6 years in the following manner:
    o	For Fermentation based products
    	20% incentive for FY 2023-24 to FY 2026-27
    	15% incentive for 2027-28  5% incentive for 2028-29
    o	For chemical synthesis based products
    	10% incentive for FY 2022-23 to FY 2027-28
    •	The applicant companies will be required to meet minimum thresholds of investment and meet the eligibility criteria to receive incentives under the scheme which has a total outlay of about INR 6,940 Cr.
    Ministry of Health & Family welfare, Govt. of India has recognized the importance of essential drugs being available and accessible at public healthcare facilities. So, in 2015, the “Free Drugs Service Initiative” (FDSI) has been launched under the National Health Mission (NHM).
    The Jan Aushadhi initiative makes available quality drugs at affordable prices through dedicated stores selling generic medicines which are available at lesser prices but are equivalent in quality and efficacy as expensive branded drugs.
    
    </p><br><br><br><br><br>

<h1 id="h">Ayushman Bharat </h1>
<p class="c3">Ayushman Bharat - Pradhan Mantri Jan Arogya Yojana (PM-JAY) is a government health insurance scheme that provides medical insurance coverage of ₹5 lakhs to the poor ...
    Establishment of Health and Wellness Centres (HWCs): These centres are aimed at improving access to affordable and quality healthcare services at the primary level. These centres provide Comprehensive Primary Health Care (CPHC), covering both maternal and child health services and non-communicable diseases, including free essential drugs and diagnostic services.
    Revised National TB Control Programme is a state-run tuberculosis control initiative of Government of India with a vision of achieving a TB free India. The program provides, various free of cost, quality tuberculosis diagnosis and treatment services across the country through the government health system.
    </p>
</div>
</body>
</html>